GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medx Health Corp (OTCPK:MDXHF) » Definitions » Gross Margin %

MDXHF (Medx Health) Gross Margin % : 37.31% (As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Medx Health Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Medx Health's Gross Profit for the three months ended in Sep. 2024 was $0.03 Mil. Medx Health's Revenue for the three months ended in Sep. 2024 was $0.07 Mil. Therefore, Medx Health's Gross Margin % for the quarter that ended in Sep. 2024 was 37.31%.

Warning Sign:

Medx Health Corp gross margin has been in long-term decline. The average rate of decline per year is -7.6%.


The historical rank and industry rank for Medx Health's Gross Margin % or its related term are showing as below:

MDXHF' s Gross Margin % Range Over the Past 10 Years
Min: 33.42   Med: 54.54   Max: 63.39
Current: 33.42


During the past 13 years, the highest Gross Margin % of Medx Health was 63.39%. The lowest was 33.42%. And the median was 54.54%.

MDXHF's Gross Margin % is ranked worse than
77.54% of 806 companies
in the Medical Devices & Instruments industry
Industry Median: 52.915 vs MDXHF: 33.42

Medx Health had a gross margin of 37.31% for the quarter that ended in Sep. 2024 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Medx Health was -7.60% per year.


Medx Health Gross Margin % Historical Data

The historical data trend for Medx Health's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medx Health Gross Margin % Chart

Medx Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.74 50.48 48.41 47.07 40.88

Medx Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.76 2.04 30.38 52.63 37.31

Competitive Comparison of Medx Health's Gross Margin %

For the Medical Devices subindustry, Medx Health's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medx Health's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medx Health's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Medx Health's Gross Margin % falls into.


;
;

Medx Health Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Medx Health's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=0.1 / 0.34
=(Revenue - Cost of Goods Sold) / Revenue
=(0.34 - 0.201) / 0.34
=40.88 %

Medx Health's Gross Margin for the quarter that ended in Sep. 2024 is calculated as


Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=0 / 0.067
=(Revenue - Cost of Goods Sold) / Revenue
=(0.067 - 0.042) / 0.067
=37.31 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Medx Health  (OTCPK:MDXHF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Medx Health had a gross margin of 37.31% for the quarter that ended in Sep. 2024 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Medx Health Gross Margin % Related Terms

Thank you for viewing the detailed overview of Medx Health's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Medx Health Business Description

Traded in Other Exchanges
Address
1495 Bonhill Road, Unit 1, Mississauga, ON, CAN, L5T 1M2
Medx Health Corp is engaged in the development, manufacturing, and marketing of skin-related screening tools and phototherapy devices for pain relief and tissue repair. Its two main product lines are; SIAscopy, a medical device technology that is used to scan skin for suspicious moles and lesions; and Phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide effective treatment of pain and tissue damage in the rehabilitation market. It derives key revenue from the sale of Phototherapeutic lasers. The company sells its products internationally, of which prime revenue is generated in Canada and the United States.